Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mettl3-mediated m6A modification of Fgf16 restricts cardiomyocyte proliferation during heart regeneration
Fu-Qing Jiang, Kun Liu, Jiaxuan Chen, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 22

Showing 22 citing articles:

RNA modification in cardiovascular disease: implications for therapeutic interventions
Cong Wang, Xuyang Hou, Qing Guan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 29
FTO mediates bisphenol F-induced blood-testis barrier impairment through regulating ferroptosis via YTHDF1/TfRc and YTHDF2/SLC7A11 signal axis
Yu Shi, Li Yin, J. Li, et al.
Environmental Pollution (2024) Vol. 359, pp. 124531-124531
Closed Access | Times Cited: 8
The Emerging Role of m6A and Programmed Cell Death in Cardiovascular Diseases
Haixia Wang, Juanjuan Han, Hui Kong, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 247-247
Open Access | Times Cited: 1
METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing
Xiaotong Wang, Jing Wang, Xibo Zhao, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 19
Epigenetic regulation of diverse regulated cell death modalities in cardiovascular disease: Insights into necroptosis, pyroptosis, ferroptosis, and cuproptosis
Cong Chen, Jie Wang, Shan Zhang, et al.
Redox Biology (2024) Vol. 76, pp. 103321-103321
Open Access | Times Cited: 8
Programmed Release METTL3-14 Inhibitor Microneedle Protects Myocardial Function by Reducing Drp1 m6A Modification-Mediated Mitochondrial Fission
Boyue Huang, Xie Liu, Ke Ming, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 40, pp. 46583-46597
Closed Access | Times Cited: 16
Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes
Hao Yang, Yuan Yang, Fedir N. Kiskin, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
RNA-Binding Proteins as Critical Post-Transcriptional Regulators of Cardiac Regeneration
De‐Li Shi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12004-12004
Open Access | Times Cited: 12
Clinical Perspectives in Epitranscriptomics
Eloy Santos-Pujol, Carlos Quero-Dotor, Manel Esteller
Current Opinion in Genetics & Development (2024) Vol. 87, pp. 102209-102209
Open Access | Times Cited: 4
Pathology and Therapeutic Significance of Fibroblast Growth Factors
Oshadi Edirisinghe, Gaëtane Ternier, Thallapuranam Krishnaswamy Suresh Kumar
Targets (2025) Vol. 3, Iss. 1, pp. 5-5
Open Access
Molecular gatekeepers of endogenous adult mammalian cardiomyocyte proliferation
Tim Koopmans, Eva van Rooij
Nature Reviews Cardiology (2025)
Closed Access
A comprehensive review of m6 A methylation in coronary heart disease
Mei-Ning Diao, Yingli Lv, Xin Hui, et al.
Journal of Molecular Medicine (2025)
Closed Access
FoxO3 controls cardiomyocyte proliferation and heart regeneration by regulating Sfrp2 expression in postnatal mice
Jing‐Bo Xia, Kun Liu, Xiaolin Lin, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
The roles of METTL3 on autophagy and proliferation of vascular smooth muscle cells are mediated by mTOR rather than by CDK1
Hanshen Luo, Xingliang Wu, Bo Huo, et al.
Cell Division (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 7
Unravelling the impact of RNA methylation genetic and epigenetic machinery in the treatment of cardiomyopathy
Li Liu, Linxing Yu, Y Wang, et al.
Pharmacological Research (2024) Vol. 207, pp. 107305-107305
Open Access | Times Cited: 2
The potential of RNA methylation in the treatment of cardiovascular diseases
Kai Wang, Yuqin Wang, Yinghui Li, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110524-110524
Open Access | Times Cited: 2
The Biological Mechanisms and Clinical Roles of RNA-Binding Proteins in Cardiovascular Diseases
Lizhu Lin, Jiemei Chu, Sanqi An, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1056-1056
Open Access | Times Cited: 2
Benzo(a)pyrene promotes the malignant progression of malignant-transformed BEAS-2B cells by regulating YTH N6-methyladenosine RNA binding protein 1 to inhibit ferroptosis
Na Wang, Hong-qiang Chen, Yong Zeng, et al.
Toxicology (2024) Vol. 507, pp. 153886-153886
Closed Access | Times Cited: 1
Epigenetic determinants and non-myocardial signaling pathways contributing to heart growth and regeneration
Jihyun Jang, Federica Accornero, Deqiang Li
Pharmacology & Therapeutics (2024) Vol. 257, pp. 108638-108638
Closed Access
A primer for Fibroblast Growth Factor 16 (FGF16)
Diana Rigueur
Differentiation (2024) Vol. 140, pp. 100817-100817
Open Access
The role of m6A modification in cardiovascular disease: A systematic review and integrative analysis
Xu-Man Feng, Yu Zhang, Ning Chen, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113603-113603
Closed Access
m6A Ribonucleic Acid Methylation in Fibrotic Diseases of Visceral Organs
Xiaoniu Dai, Yusi Cheng, Wei Luo, et al.
Small Science (2024)
Open Access
Page 1

Scroll to top